EIKN
Eikon Therapeutics, Inc.
8.00$
+1.6%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
Eikon Therapeutics, Inc. (EIKN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -189 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| -191 | -135 | -189 | |
| 18 | 25 | 24 | |
| 9.5 | 12 | 18 | |
| 10.0 | 81 | 78 | |
| 29 | 85 | 47 | |
| – | – | -181 | |
| 106 | 0.2 | 352 | |
| 52 | 17 | -18 | |
| -219 | -220 | -235 |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.